190 related articles for article (PubMed ID: 19204325)
21. Vasohibin: the feedback on a new inhibitor of angiogenesis.
Kerbel RS
J Clin Invest; 2004 Oct; 114(7):884-6. PubMed ID: 15467823
[TBL] [Abstract][Full Text] [Related]
22. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
[TBL] [Abstract][Full Text] [Related]
23. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors.
Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH
Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699
[TBL] [Abstract][Full Text] [Related]
24. The roles of vasohibin and its family members: Beyond angiogenesis modulators.
Du H; Zhao J; Hai L; Wu J; Yi H; Shi Y
Cancer Biol Ther; 2017 Nov; 18(11):827-832. PubMed ID: 28886304
[TBL] [Abstract][Full Text] [Related]
25. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
26. Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells.
Kozako T; Matsumoto N; Kuramoto Y; Sakata A; Motonagare R; Aikawa A; Imoto M; Toda A; Honda S; Shimeno H; Soeda S
FEBS Lett; 2012 Apr; 586(7):1067-72. PubMed ID: 22569265
[TBL] [Abstract][Full Text] [Related]
27. Vasohibin attenuates bleomycin induced pulmonary fibrosis via inhibition of angiogenesis in mice.
Wang X; Zhu H; Yang X; Bi Y; Cui S
Pathology; 2010; 42(5):457-62. PubMed ID: 20632823
[TBL] [Abstract][Full Text] [Related]
28. Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin.
Sonoda H; Ohta H; Watanabe K; Yamashita H; Kimura H; Sato Y
Biochem Biophys Res Commun; 2006 Apr; 342(2):640-6. PubMed ID: 16488400
[TBL] [Abstract][Full Text] [Related]
29. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
[TBL] [Abstract][Full Text] [Related]
30. Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.
Tamaki K; Moriya T; Sato Y; Ishida T; Maruo Y; Yoshinaga K; Ohuchi N; Sasano H
Cancer Sci; 2009 Jan; 100(1):88-94. PubMed ID: 19037993
[TBL] [Abstract][Full Text] [Related]
31. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
Huang B; Huang M; Li Q
Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
[TBL] [Abstract][Full Text] [Related]
32. Delta-like 4 and vasohibin 1: two endothelium-produced negative regulators of angiogenesis with distinctive roles.
Sato Y
Eur Cytokine Netw; 2009 Dec; 20(4):220-4. PubMed ID: 20167561
[TBL] [Abstract][Full Text] [Related]
33. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
[TBL] [Abstract][Full Text] [Related]
34. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
35. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
[TBL] [Abstract][Full Text] [Related]
36. Age-associated downregulation of vasohibin-1 in vascular endothelial cells.
Takeda E; Suzuki Y; Sato Y
Aging Cell; 2016 Oct; 15(5):885-92. PubMed ID: 27325558
[TBL] [Abstract][Full Text] [Related]
37. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R
Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230
[TBL] [Abstract][Full Text] [Related]
38. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
[TBL] [Abstract][Full Text] [Related]
39. Loss of Estrogen-Related Receptor Alpha Facilitates Angiogenesis in Endothelial Cells.
Likhite N; Yadav V; Milliman EJ; Sopariwala DH; Lorca S; Narayana NP; Sheth M; Reineke EL; Giguère V; Narkar V
Mol Cell Biol; 2019 Mar; 39(5):. PubMed ID: 30602497
[TBL] [Abstract][Full Text] [Related]
40. Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity.
Sato Y
J Atheroscler Thromb; 2018 Jun; 25(6):461-466. PubMed ID: 29398681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
